GRACEcast - Discussions with the Global Resource for Advancing Cancer Education

Follow GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
Share on
Copy link to clipboard

In this podcast series, the Global Resource for Advancing Cancer Education (GRACE) works to bring professionals together with patients and caregivers to work in partnership. We interview patients, advocates and healthcare professionals to provide the most updated information for our community and to highlight important issues facing those dealing with a cancer diagnosis. For more information visit www.cancerGRACE.org. To join the conversation, visit https://cancergrace.org/forums

cancerGRACE Meetings


    • Mar 5, 2025 LATEST EPISODE
    • monthly NEW EPISODES
    • 6m AVG DURATION
    • 221 EPISODES


    Search for episodes from GRACEcast - Discussions with the Global Resource for Advancing Cancer Education with a specific topic:

    Latest episodes from GRACEcast - Discussions with the Global Resource for Advancing Cancer Education

    Trials in EGFR Mutated NSCLC: Flaura2 and Mariposa- 2024 Leading Developments in Lung Cancer

    Play Episode Listen Later Mar 5, 2025 10:53


    Drs. Desai and Abu Rous discuss trial data from Flaura2 and Mariposa as presented at 2024 ASCO, and the implications in treating EGFR+ NSCLC.

    Trials in ALK+ NSCLC: The Crown Study- 2024 Leading Developments in Lung Cancer

    Play Episode Listen Later Feb 26, 2025 3:47


    Drs. Desai and Abu Rous discuss the Crown study data as presented at ASCO 2024, and its implications in treating ALK+ NSCLC.

    Limited Stage Small Cell Lung Cancer: The Adriatic Study- 2024 Leading Developments in Lung Cancer

    Play Episode Listen Later Feb 19, 2025 4:22


    Drs. Desai and Abu Rous discuss the  data, as presented at ASCO 2024, and how it may change the field of treatment for limited stage small Adriatic Studycell lung cancer.

    Trials in EGFR Mutated NSCLC: Mariposa2 and Laura- 2024 Leading Developments in Lung Cancer

    Play Episode Listen Later Feb 12, 2025 6:26


    Drs. Desai and Abu Rous discuss trial date from Mariposa2 and Laura as presented at 2024 ASCO, and the implications in treating EGFR+ NSCLC.

    Tarlatamab for Extensive Stage Small Cell Lung Cancer- 2024 Leading Developments in Lung Cancer

    Play Episode Listen Later Feb 7, 2025 7:01


    Drs. Desai and Abu Rous discuss using tarlatamab in treating extensive stage small cell lung cancer.

    Advances in Thyroid Cancer Treatment

    Play Episode Listen Later Aug 29, 2024 10:01


    Drs. Patel, Sheth, and Weiss discuss emerging data and advances in thyroid cancer treatment.

    Incurable HPV Negative Head and Neck Cancer

    Play Episode Listen Later Aug 21, 2024 13:15


    Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in incurable HPV negative head and neck cancer.

    Recurrent/Metastatic HPV Positive Head and Neck Cancer

    Play Episode Listen Later Aug 14, 2024 7:56


    Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in recurrent/metastatic HPV positive head and neck cancer.

    Curable HPV Negative Head and Neck Cancer

    Play Episode Listen Later Aug 7, 2024 5:38


    Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in curable HPV negative head and neck cancer.

    Curable HPV Positive Head and Neck Cancer

    Play Episode Listen Later Jul 30, 2024 11:47


    Drs. Patel, Sheth, and Weiss discuss current treatment options and emerging data in curable HPV positive head and neck cancer.

    What is a Bone Marrow Transplant?

    Play Episode Listen Later Jun 12, 2024 8:11


    Dr. Marco Ruiz explains the concept of bone marrow transplant, and how it is used in treating blood cancers.

    Q&A: Do People in Rural Communities Have Equal Access to Treatment Options?

    Play Episode Listen Later Jun 10, 2024 4:12


    Drs. Goodman, Phillips, Taneja, and Rajeeve discuss whether a patient's location can affect the treatments they can access and their overall prognosis.

    Q&A: Is my Clinical Trial Affecting my Body's Reaction to the Covid-19 Vaccine?

    Play Episode Listen Later Jun 5, 2024 4:02


    Drs. Goodman, Phillips, Taneja, and Rajeeve discuss how to navigate treatment and Covid vaccination.

    Bispecific Antibodies in Myeloma: Approvals and Clinical Trials

    Play Episode Listen Later May 31, 2024 4:11


    Dr. Sridevi Rajeeve discusses current FDA approved bispecific antibodies and ones coming from clinical trials.

    Curative Strategies for Patients with Smoldering Multiple Myeloma

    Play Episode Listen Later May 23, 2024 3:05


    Dr. Alankrita Taneja examines data from the CESAR trial, and discusses curative strategies for Smoldering Multiple Myeloma.

    Management of Bispecific Antibodies Side Effects

    Play Episode Listen Later May 17, 2024 3:10


    Dr. Sridevi Rajeeve discusses possible side effects from bispecific antibodies, and how to manage them.

    Teclistamab, Talquetamab, and Elranatamab: Response Rates and Data

    Play Episode Listen Later May 10, 2024 6:03


    Dr. Sridevi Rajeeve discusses the unprecedented response rates in patients treated with teclistamab, talquetamab, and elranatamab, as well as their clinical trial data.

    Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma

    Play Episode Listen Later May 3, 2024 3:02


    Dr. Tycel Phillips examines the efficacy of two medications against diffuse large b-cell lymphoma (DLBCL)

    Barriers to Biomarker Testing: Cost and Insurance

    Play Episode Listen Later Apr 27, 2024 3:30


    Dr. Aakash Desai discusses how to address the issues of cost and insurance approval when obtaining biomarker testing.

    Barriers to Biomarker Testing: Ordering Tests

    Play Episode Listen Later Apr 20, 2024 6:23


    Dr. Aakash Desai emphasizes the importance of physicians ordering biomarker testing for patients with NSCLC

    The Adaura Trial: The Effect on EGFR+ Treatment

    Play Episode Listen Later Apr 15, 2024 6:26


    Dr. Joshua Reuss discusses the ADAURA trial, which suggested Osimertinib as treatment for EGFR+ NSCLC.

    Biomarker Driven Therapy for NSCLC

    Play Episode Listen Later Apr 13, 2024 5:13


    Dr. Aakash Desai discusses the administration of therapy for biomarkers, and how to overcome the gaps in administration, access, and affordability.

    Current Recommendations and Best Practices for Biomarker Testing

    Play Episode Listen Later Apr 11, 2024 3:53


    Dr. Aakash Desai discusses the current recommendations for biomarker testing in patients with NSCLC, as well as best practices.

    The Importance of Biomarker Testing: What is Liquid Biopsy?

    Play Episode Listen Later Apr 9, 2024 4:55


    Dr. Aakash Desai details the importance of biomarker testing, and discusses the method of liquid biopsy to do so.

    Biomarkers in NSCLC

    Play Episode Listen Later Apr 9, 2024 5:55


    Dr. Aakash Desai gives a basic overview of biomarkers, and discusses which ones are important for patients with NSCLC.

    Key Points from the Adaura Trial: Osimertinib

    Play Episode Listen Later Nov 30, 2023 6:14


    Dr. Joshua Reuss examines important details learned during the ADAURA trial, including overall survival, reduced risk of brain mets, and side effects.

    Biomarkers in NSCLC

    Play Episode Listen Later Nov 23, 2023 5:55


    Dr. Aakash Desai gives a basic overview of biomarkers, and discusses which ones are important for patients with NSCLC.

    The Importance of Biomarker Testing: What is Liquid Biopsy?

    Play Episode Listen Later Nov 16, 2023 4:55


    Dr. Aakash Desai details the importance of biomarker testing, and discusses the method of liquid biopsy to do so.

    Barriers to Biomarker Testing: Cost and Insurance

    Play Episode Listen Later Nov 10, 2023 3:30


    Dr. Aakash Desai discusses how to address the issues of cost and insurance approval when obtaining biomarker testing.

    Neoadjuvant Treatment for Patients with NSCLC

    Play Episode Listen Later Oct 27, 2023 3:11


    Dr. Joshua Reuss examines data on neoadjuvant targeted therapy.

    The Alina Trial for ALK+ NSCLC

    Play Episode Listen Later Oct 21, 2023 1:13


    Dr. Joshua Reuss gives a brief description of the ongoing Alina trial for patients with ALK+ NSCLC.

    Local Therapy for Limited Metastatic NSCLC

    Play Episode Listen Later Oct 17, 2023 4:17


    Dr. Puneeth Iyengar discusses the concept of using local therapy as an additional treatment for limited metastatic NSCLC, including Stereotactic Body Radiation Therapy (SBRT).

    Immunotherapy for Patients with Resectable NSCLC and a Driver Mutation

    Play Episode Listen Later Oct 10, 2023 2:05


    Dr. Joshua Reuss explains why immunotherapy is not typically given to patients with resectable NSCLC and a driver mutation.

    Treatment Options for Patients with Locally Advanced Unresectable NSCLC

    Play Episode Listen Later Oct 3, 2023 1:59


    Dr. Joshua Reuss discusses treatment options for patients with locally advanced NSCLC, and how to proceed while waiting for trial data.

    Local Therapy for NSCLC Patients After Frontline Therapy

    Play Episode Listen Later Sep 27, 2023 7:52


    Dr. Puneeth Iyengar discusses local therapy options for patients with metastatic disease who have received a front line therapy.

    The Role of the Patient as Advocate

    Play Episode Listen Later Sep 24, 2023 2:59


    Dr. Joshua Reuss discusses what the patient can do to advocate for themselves during treatment.

    Targeted Therapy Before Surgery in Patients with Resectable NSCLC and Driver Mutation

    Play Episode Listen Later Sep 20, 2023 3:12


    Dr. Joshua Reuss discusses considerations and questions for targeted therapy before surgery.

    Local Therapy for Patients with Oligoprogressive NSCLC

    Play Episode Listen Later Sep 15, 2023 5:27


    Dr. Puneeth Iyengar discusses local therapy treatment options for patients who have oligoprogressive disease.

    The Future of Local Therapy in Lung Cancer

    Play Episode Listen Later Sep 14, 2023 2:55


    Dr. Puneeth Iyengar examines what has been learned from studies, what still remains unanswered, and future directions of local therapy treatments for patients with NSCLC.

    Adding to Targeted Therapy: Current Statistics and Biology

    Play Episode Listen Later Sep 14, 2023 5:17


    Dr. Puneeth Iyengar looks at current statistics for methods of adding to targeted therapy, as well as giving an overview of biology in treatment.

    The Importance of Prostate Cancer Screening

    Play Episode Listen Later Sep 1, 2023 3:45


    Dr. Rana McKay discusses why it's crucial to get a prostate cancer screening.

    सामान्य परामर्श मुद्दे (Common Consultation Issues)

    Play Episode Listen Later Aug 30, 2023 3:52 Transcription Available


    डॉ. अलंकृता तनेजा ट्रांसजेंडर मरीजों में देखे जाने वाले सामान्य परामर्श मुद्दों पर चर्चा करती हैं, और सही मॉनिटरिंग का महत्व बताती हैं।(Dr. Alankrita Taneja discusses common consultation issues seen in transgender patients, and the importance of proper monitoring.)

    पुरुषत्वीकरण चिकित्सा और द्वितीय एरिथ्रोसाइटोसिस (Masculinizing Therapy and Secondary Erythrocytosis)

    Play Episode Listen Later Aug 23, 2023 8:01 Transcription Available


    डॉ. अलंकृता तनेजा टेस्टोस्टेरोन थेरेपी और इसके साथ आने वाले जोखिमों पर चर्चा करती हैं, जिसमें द्वितीय एरिथ्रोसाइटोसिस भी शामिल है।(Dr. Alankrita Taneja discusses testosterone therapy and the risks that come with it, including secondary erythrocytosis.)

    सिकल सेल रोग और जेंडर अफर्मिंग हार्मोन थेरेपी (Sickle Cell Disease and Gender Affirming Hormone Therapy)

    Play Episode Listen Later Aug 16, 2023 3:09 Transcription Available


    डॉ. अलंकृता तनेजा सिकल सेल रोग वाले लोगों के लिए उपचार विकल्पों की जांच करती हैं, जो जेंडर अफर्मिंग हार्मोन थेरेपी के अधीन हैं।(Dr. Alankrita Taneja examines the treatment options for people with Sickle Cell Disease who are undergoing gender affirming hormone therapy.)

    फेमिनाइजिंग थेरेपी और थ्रोम्बोसिस (Feminizing Therapy and Thrombosis)

    Play Episode Listen Later Aug 9, 2023 9:37 Transcription Available


    डॉ. अलंकृता तनेजा एस्ट्रोजन थेरेपी और इसके संभावित दुष्प्रभावों की जांच करती हैं।(Dr. Alankrita Taneja examines estrogen therapy and its potential side effects.)

    भारत में ट्रांसजेंडर मुद्दे (Transgender Issues in India)

    Play Episode Listen Later Aug 4, 2023 3:05 Transcription Available


    डॉ. अलंकृता तनेजा भारत में ट्रांसजेंडर लोगों के संबंधित शब्दावली और सामाजिक मुद्दों का एक संक्षिप्त विवरण देती है।(Dr. Alankrita Taneja gives a brief description of terminology and social issues surrounding transgender people in India.)

    Neoadjuvant Therapy in Melanoma: Does It Give a Better Immune Response?

    Play Episode Listen Later Jun 7, 2023 5:36


    Dr. Vernon Sondak makes the argument that neoadjuvant therapy leads to a better immune response in patients with melanoma.

    Neoadjuvant Therapy for Melanoma

    Play Episode Listen Later Jun 2, 2023 7:26


    Dr. Vernon Sondak discusses the pros and cons of neoadjuvant therapy, or receiving treatment before surgery.

    Adjuvant Therapy for Melanoma

    Play Episode Listen Later May 29, 2023 3:14


    Dr. Vernon Sondak discusses the pros and cons of adjuvant therapy, or receiving treatment after surgery.

    Adjuvant Therapy in Stage 3 and 4 Melanoma

    Play Episode Listen Later May 26, 2023 5:42


    Dr. Meredith McKean discusses recent findings in adjuvant therapy for patients with stage 3 or 4 melanoma.

    Patient Selection for First Line Therapy in Stage 4 Melanoma

    Play Episode Listen Later May 22, 2023 6:00


    Dr. Vernon Sondak discusses current patient treatment standards, including using immune therapy before targeted therapy in unresectable stage 4 disease.

    Claim GRACEcast - Discussions with the Global Resource for Advancing Cancer Education

    In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

    Claim Cancel